Antiplatelet and antithrombotic effects of organic nitrates - PubMed (original) (raw)
Review
Antiplatelet and antithrombotic effects of organic nitrates
J Loscalzo. Am J Cardiol. 1992.
Abstract
Organic nitrates are believed to provide relief from angina principally by dilating the coronary vasculature. Substantial evidence exists, however, to support a potent antiplatelet effect for these agents as well. Each of these compounds ultimately is metabolized to nitric oxide (or an S-nitrosothiol congener thereof), and this metabolite, in turn, is a potent activator of platelet guanylate cyclase. Activation of guanylate cyclase increases platelet cyclic guanosine monophosphate (cGMP), and is accompanied by inhibition of agonist-mediated calcium flux, and, in turn, reduction of fibrinogen binding to the glycoprotein IIb/IIIa receptor. Since fibrinogen binding is essential for platelet aggregation regardless of the agonist involved, its inhibition appears to be the critical mechanism by which platelet function is impaired by these agents. The recently recognized role that platelet-dependent thrombotic processes play in acute coronary syndromes suggests that the inhibition of platelets by nitrates may offer an additional mechanism by which these compounds improve perfusion to ischemic myocardium.
Similar articles
- Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo.
Apostoli GL, Solomon A, Smallwood MJ, Winyard PG, Emerson M. Apostoli GL, et al. J Thromb Haemost. 2014 Nov;12(11):1880-9. doi: 10.1111/jth.12711. Epub 2014 Oct 1. J Thromb Haemost. 2014. PMID: 25163536 - The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders.
Stamler JS, Loscalzo J. Stamler JS, et al. J Am Coll Cardiol. 1991 Nov 15;18(6):1529-36. doi: 10.1016/0735-1097(91)90686-4. J Am Coll Cardiol. 1991. PMID: 1939957 Review. - Direct inhibition of platelet function by organic nitrates via nitric oxide formation.
Weber AA, Strobach H, Schrör K. Weber AA, et al. Eur J Pharmacol. 1993 Sep 15;247(1):29-37. doi: 10.1016/0922-4106(93)90134-u. Eur J Pharmacol. 1993. PMID: 8258358 - Platelet hyperaggregability: impaired responsiveness to nitric oxide ("platelet NO resistance") as a therapeutic target.
Rajendran S, Chirkov YY. Rajendran S, et al. Cardiovasc Drugs Ther. 2008 Jun;22(3):193-203. doi: 10.1007/s10557-008-6098-7. Epub 2008 Mar 11. Cardiovasc Drugs Ther. 2008. PMID: 18327704 Review. - A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
Crane MS, Rossi AG, Megson IL. Crane MS, et al. Br J Pharmacol. 2005 Mar;144(6):849-59. doi: 10.1038/sj.bjp.0706110. Br J Pharmacol. 2005. PMID: 15685209 Free PMC article.
Cited by
- Characterization of furoxans as a new class of tolerance-resistant nitrovasodilators.
Hecker M, Vorhoff W, Bara AT, Mordvintcev PI, Busse R. Hecker M, et al. Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):426-32. doi: 10.1007/BF00169084. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7630432 - Attenuated severity of new acute ischemic events in patients with previous coronary heart disease receiving long-acting nitrates.
García-Dorado D, Permanyer-Miralda G, Brotons C, Calvo F, Campreciós M, Oliveras J, Santos MT, Moral I, Soler-Soler J. García-Dorado D, et al. Clin Cardiol. 1999 Apr;22(4):303-8. doi: 10.1002/clc.4960220410. Clin Cardiol. 1999. PMID: 10198741 Free PMC article. Clinical Trial. - Regulation of platelet granule exocytosis by S-nitrosylation.
Morrell CN, Matsushita K, Chiles K, Scharpf RB, Yamakuchi M, Mason RJ, Bergmeier W, Mankowski JL, Baldwin WM 3rd, Faraday N, Lowenstein CJ. Morrell CN, et al. Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3782-7. doi: 10.1073/pnas.0408310102. Epub 2005 Feb 28. Proc Natl Acad Sci U S A. 2005. PMID: 15738422 Free PMC article. - Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.
Rogers NM, Ghimire K, Calzada MJ, Isenberg JS. Rogers NM, et al. Cardiovasc Res. 2017 Jul 1;113(8):858-868. doi: 10.1093/cvr/cvx094. Cardiovasc Res. 2017. PMID: 28472457 Free PMC article. Review. - Nitrate tolerance in angina therapy. How to avoid it.
Rutherford JD. Rutherford JD. Drugs. 1995 Feb;49(2):196-9. doi: 10.2165/00003495-199549020-00004. Drugs. 1995. PMID: 7729327 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical